692 results match your criteria: "First Affiliated Hospital of Henan University of Science and Technology[Affiliation]"

Genomic imprinting biomarkers for cervical cancer risk stratification.

Cancer Commun (Lond)

December 2024

Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, Sichuan, P. R. China.

View Article and Find Full Text PDF
Article Synopsis
  • * To improve Image Quality Assessment (IQA) for distorted images, a new method using the Swin Transformer (ST) with a Global Self-Attention Block (GSAB) is proposed, allowing the model to effectively focus on spatial and channel information.
  • * Experiments conducted on multiple synthetic and authentic datasets demonstrate that this new method outperforms existing techniques and shows strong generalization ability, providing promising results in predicting image quality scores.
View Article and Find Full Text PDF

Background: Cell death, including apoptosis and necrosis, collectively known as widespread apoptosis. The present study aims to investigate the mechanism of action in widespread apoptosis-related modification patterns in bladder cancer.

Methods: Using a clinical genomics database, we obtained transcriptomic data and related clinical information of bladder cancer patients.

View Article and Find Full Text PDF

Background: Patients with irritable bowel syndrome (IBS) often have chronic low-grade inflammation in the intestinal mucosa. Some dietary components are known to be associated with inflammation. However, there is currently limited research on the relationship between dietary inflammatory potential and the risk of IBS.

View Article and Find Full Text PDF

Potent covalent irreversible inhibitor of KRAS G12C IBI351 in patients with advanced solid tumors: First-in-human phase I study.

Eur J Cancer

November 2024

Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. Electronic address:

Article Synopsis
  • IBI351 is an irreversible, covalent inhibitor specifically targeting the KRAS G12C mutation in advanced solid tumors, particularly among Chinese patients, addressing unmet clinical needs even after FDA-approved therapies exist.
  • In a clinical study involving 176 patients, various doses of IBI351 were tested, with the recommended dose set at 600 mg taken twice daily, showing no major toxic effects while still being effective.
  • The treatment demonstrated a 45.5% overall response rate in patients with non-small cell lung cancer, with promising results, including a 9.6-month median progression-free survival at the optimal dosage.
View Article and Find Full Text PDF

Background: Breast cancer (BC) is the most common cancer in women and poses a significant health burden, especially in China. Despite advances in diagnosis and treatment, patient variability and limited early detection contribute to poor outcomes. This study examines the role of CD8 + T cells in the tumor microenvironment to identify new biomarkers that improve prognosis and guide treatment strategies.

View Article and Find Full Text PDF
Article Synopsis
  • - The study assessed the safety and effectiveness of combining camrelizumab and apatinib in patients with advanced esophageal squamous cell carcinoma (ESCC) who previously received immune checkpoint inhibitors (ICIs).
  • - Out of 49 patients treated, the confirmed objective response rate was 10.2%, with a disease control rate of 69.4% and median progression-free survival of 4.6 months.
  • - The results indicated that the response rate was modest and did not show significant improvement, though the treatment had a manageable safety profile with no treatment-related deaths reported.
View Article and Find Full Text PDF
Article Synopsis
  • Liposomal irinotecan (HR070803) combined with 5-fluorouracil and leucovorin shows enhanced overall survival in patients with advanced pancreatic cancer previously treated with gemcitabine-based therapies, as demonstrated in a phase 3 study.
  • The trial involved 298 patients, showing a median overall survival of 7.4 months for the HR070803 group compared to 5.0 months for the placebo group, with statistically significant results.
  • While there were some adverse events, such as increased liver enzyme levels and decreased white blood cell counts, the safety profile was manageable, with no treatment-related deaths in the HR070803 group, highlighting its potential as a second-line treatment option for this patient
View Article and Find Full Text PDF
Article Synopsis
  • The study focused on understanding osteonecrosis of the femoral head (ONFH) and its connection to hip cartilage degeneration and identified key molecular mechanisms involved in its progression.
  • A multiomics approach was used to analyze hip cartilage samples from 36 patients, revealing 22 differentially expressed genes (DEGs) and their associated pathways linked to cartilage degeneration.
  • The research uncovered ten significant chemicals related to ONFH, offering new insights into the disease's causes and biological processes.
View Article and Find Full Text PDF

Sex disparities of clinical manifestations in acute pulmonary embolism and predictive value for in-hospital mortality: Insights from CURES.

Thromb Res

November 2024

China-Japan Friendship Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, China; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Me

Article Synopsis
  • The study examines gender differences in clinical manifestations and in-hospital mortality rates for patients with pulmonary embolism (PE), revealing that males face a higher risk of death during hospitalization compared to females.
  • Data was analyzed from over 15,000 patients, showing that males reported symptoms like chest pain and hemoptysis more frequently, while females experienced higher rates of dyspnea and fever.
  • Results indicated that specific symptoms were linked to increased mortality, highlighting the importance of recognizing these gender-specific differences in clinical settings.
View Article and Find Full Text PDF

Background: Aerobic glycolysis and the cell cycle are well-established tumor hallmarks. Understanding their relationship could help to unravel the pathogenic mechanisms of breast cancer (BC) and suggest potential new strategies for treatment.

Methods: Glycolysis-related genes (GRGs) were downloaded from the Reactome database and screened using univariate Cox analysis.

View Article and Find Full Text PDF

Objective: Patients who carry NUP98::NSD1 or FLT3/ITD mutations are reported to have poor prognosis. Previous studies have confidently reported that the poor outcome in younger AML patients is owning to dual NUP98::NSD1 and FLT3/ITD positivity, with a high overlap for those two genetic lesions. In this study, we assessed the prognostic value of the presence of both NUP98::NSD1 and FLT3/ITD in pediatric AML patients.

View Article and Find Full Text PDF

Background: Pancreatic ductal adenocarcinoma (PDAC) often presents with liver or peritoneal metastases at diagnosis. Despite similar treatment approaches, patient outcomes vary between these metastatic sites. To improve targeted therapies for metastatic PDAC, a comprehensive analysis of the genetic profiles and evolutionary patterns at these distinct metastatic locations is essential.

View Article and Find Full Text PDF

Self-propelled nanomotors possess strong propulsion and penetration abilities, which can increase the efficiency of cellular uptake of nanoparticles and enhance their cytotoxicity against tumor cells, opening a new path for treating major diseases. In this study, the concept of driving nanomotors by alternately stretching and contracting a temperature-sensitive polymer (TS-P) chain is proposed. The TS-Ps are successfully linked to one side of CuSe@Au (CS@Au) nanoparticles to form a Janus structure, which is designated as CuSe@Au-polymer (CS@Au-P) nanomotors.

View Article and Find Full Text PDF

Importance: Many patients with diabetic peripheral neuropathic pain (DPNP) experience inadequate relief, despite best available medical treatments. There are no approved and effective therapies for patients with DPNP in China.

Objective: To evaluate the efficacy and safety of capsules containing γ-aminobutyric acid (GABA) analogue HSK16149 in the treatment of Chinese patients with DPNP.

View Article and Find Full Text PDF

In this report, the patient was a 57-year-old woman who had been diagnosed with aplastic anemia for 3 years. This patient underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT). Twenty-four months after allo-HSCT, the patient experienced cognitive dysfunction, memory loss, and involuntary movements.

View Article and Find Full Text PDF

Background: A stent with characteristics of a hybrid design may have advantages in improving the patency of symptomatic iliofemoral vein obstruction. This study assessed the safety and effectiveness of the V-Mixtent Venous Stent in treating symptomatic iliofemoral outflow obstruction.

Methods: Eligible patients had a Clinical-Etiologic-Anatomic-Physiologic (CEAP) C classification of ≥ 3 or a Venous Clinical Severity Score (VCSS) pain score of ≥ 2.

View Article and Find Full Text PDF

Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study.

Lancet Respir Med

September 2024

Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. Electronic address:

Article Synopsis
  • - The study evaluates foritinib, a new treatment for patients with advanced ROS1-rearranged non-small-cell lung cancer (NSCLC), aiming to improve upon existing therapies that struggle with brain activity or safety.
  • - Conducted in China, the two-part clinical trial involved 104 patients with varying previous treatments and aimed to assess the drug's effectiveness and safety through objective response rates and safety assessments.
  • - Initial findings, gathered over nearly three years, monitored patient outcomes and noted adjustments in study protocols, particularly regarding participant eligibility related to prior ROS1 inhibitor use.
View Article and Find Full Text PDF

Background: Esophageal squamous cell carcinoma (ESCC) is a deadly type of esophageal cancer. Programmed cell death (PCD) is an important pathway of cellular self-extermination and is closely involved in cancer progression. A detailed study of its mechanism may contribute to ESCC treatment.

View Article and Find Full Text PDF

Association between coronary artery stenosis and myocardial injury in patients with acute pulmonary embolism: A case-control study.

Chin Med J (Engl)

August 2024

Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China.

Background: The potential impact of pre-existing coronary artery stenosis (CAS) on acute pulmonary embolism (PE) episodes remains underexplored. This study aimed to investigate the association between pre-existing CAS and the elevation of high-sensitivity cardiac troponin I (hs-cTnI) levels in patients with PE.

Methods: In this multicenter, prospective case-control study, 88 cases and 163 controls matched for age, sex, and study center were enrolled.

View Article and Find Full Text PDF

Background: CD83 are closely related to the pathogenesis of immune thrombocytopenia (ITP), but the exact mechanism remains unclear.

Aim: To explore the relationship between CD83 and CD4 T cell subsets and clarify the role of CD83 in the pathogenesis of ITP.

Methods: RT-qPCR and Flow cytometry were used to illustrate CD83 expression.

View Article and Find Full Text PDF

Background: Gastric cancer is the fifth most common cancer and the fourth most common cause of cancer death worldwide, yet the prognosis of advanced disease remains poor.

Methods: This was a randomized, double-blinded, phase 2 trial (ClinicalTrials.gov: NCT04908813).

View Article and Find Full Text PDF

Objectives: To screen programmed cell death (PCD)-related genes in esophageal squamous cell carcinoma (ESCC) based on transcriptomic data and to explore its clinical value.

Methods: Differentially expressed PCD genes (DEPCDGs) were screened from ESCC transcriptome and clinical data in TCGA database. Univariate COX and LASSO COX were performed on prognostically DEPCDGs in ESCC to develop prognostic model.

View Article and Find Full Text PDF